Xencor Inc (XNCR)

Exchange
NASDAQ
Symbol
XNCR
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of cytokine and monoclonal antibody therapies designed to treat cancer patients and autoimmune diseases in the United States and internationally. The company is headquartered in Monrovia, California.
Country
USA

Stock price

At close: March 7, 2025

  • Open
    13.86
  • High
    14.02
  • Low
    13.59
  • Close
    13.87
  • Volume
    430,444

Financial ratios

Dec 31, 2023